Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity
- PMID: 3105248
- DOI: 10.1111/j.1699-0463.1986.tb02108.x
Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity
Abstract
The effect of Pseudomonas aeruginosa alkaline protease (AP) and elastase (Ela) on neutrophil phagocytosis and bactericidal activity was examined. It was found that both proteases reduced the phagocytic activity of the leukocytes against P. aeruginosa, whereas they had little effect on the phagocytosis of S. aureus. AP and Ela at concentration of up to 250 micrograms per ml (much higher than the levels detectable under in vivo conditions) did not interfere with the bactericidal activity of the leukocytes against both test organisms. Inhibition of phagocytosis by AP and Ela without effect on the bactericidal activity suggests that the P. aeruginosa proteases most probably exert their effect on the cell surface perhaps by proteolytic cleavage of the cell receptors which are necessary for phagocytosis.
Similar articles
-
Interaction of pseudomonas exoproducts with phagocytic cells.Can J Microbiol. 1982 Jun;28(6):679-85. doi: 10.1139/m82-102. Can J Microbiol. 1982. PMID: 6811122
-
Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.Infect Immun. 1988 Jul;56(7):1673-7. doi: 10.1128/iai.56.7.1673-1677.1988. Infect Immun. 1988. PMID: 3133317 Free PMC article.
-
Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase.Infect Immun. 1987 Apr;55(4):986-9. doi: 10.1128/iai.55.4.986-989.1987. Infect Immun. 1987. PMID: 3030937 Free PMC article.
-
Pseudomonas aeruginosa elastase and its role in pseudomonas infections.Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S998-1004. doi: 10.1093/clinids/5.supplement_5.s998. Rev Infect Dis. 1983. PMID: 6419322 Review.
-
The role of bacterial proteases in the pathogenesis of cystic fibrosis.Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S118-22. doi: 10.1164/ajrccm/150.6_Pt_2.S118. Am J Respir Crit Care Med. 1994. PMID: 7952646 Review.
Cited by
-
Recent developments for Pseudomonas vaccines.Hum Vaccin. 2011 Oct;7(10):999-1011. doi: 10.4161/hv.7.10.16369. Epub 2011 Oct 1. Hum Vaccin. 2011. PMID: 21941090 Free PMC article. Review.
-
Innate Immune Signaling Activated by MDR Bacteria in the Airway.Physiol Rev. 2016 Jan;96(1):19-53. doi: 10.1152/physrev.00009.2015. Physiol Rev. 2016. PMID: 26582515 Free PMC article. Review.
-
Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections.Antibiotics (Basel). 2021 Dec 14;10(12):1530. doi: 10.3390/antibiotics10121530. Antibiotics (Basel). 2021. PMID: 34943742 Free PMC article. Review.
-
The Legionella pneumophila major secretory protein, a protease, is not required for intracellular growth or cell killing.Infect Immun. 1990 Aug;58(8):2585-92. doi: 10.1128/iai.58.8.2585-2592.1990. Infect Immun. 1990. PMID: 2164510 Free PMC article.
-
Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation.Front Immunol. 2018 Jul 23;9:1675. doi: 10.3389/fimmu.2018.01675. eCollection 2018. Front Immunol. 2018. PMID: 30083156 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources